Communiqués Talphera, Inc.

Actions

TLPH

US00444T2096

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 10/09/2026			Varia. 5j.	Varia. 1 janv.
1,240 ^USD	+1,64%		+3,33%	+8,77%

12/08	Transcript : Talphera, Inc., Q2 2026 Earnings Call, Aug 12, 2026
12/08	Talphera, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

03/09	Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference	PR
12/08	Talphera: Q2 Earnings Snapshot	AQ
12/08	Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update	PR
05/08	Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026	PR
13/05	Talphera: Q1 Earnings Snapshot	AQ
13/05	Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update	PR
07/05	Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026	PR
26/03	Talphera Announces Two Abstracts Accepted for Presentation at AKI and CRRT 2026	AQ
25/03	Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026	PR
23/03	Talphera: Q4 Earnings Snapshot	AQ
23/03	Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update	PR
18/03	Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026	PR
02/03	Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial	PR
12/11	Talphera: Q3 Earnings Snapshot	AQ
05/11	Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025	PR
09/09/25	Ninth Circuit Affirms Dismissal Of Securities Fraud Suit: Marketing Slogan Alone Not Actionable Under Section 10(b) And Rule 10b-5	AQ
08/09/25	CorMedix Announces Strategic Minority Investment in Talphera	AQ
27/08/25	Ninth Circuit Affirms Dismissal Of Putative Class Action Against Pharmaceutical Company For Failure To Adequately Allege Falsity And Scienter	AQ
25/08/25	Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial	PR
14/08/25	Talphera: Q2 Earnings Snapshot	AQ
14/08/25	Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update	PR
07/08/25	Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025	PR
14/05/25	Talphera: Q1 Earnings Snapshot	AQ
08/05/25	Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025	AQ
31/03/25	Talphera: Q4 Earnings Snapshot	AQ